- Additional Authors
- Uniform Title
- Online access: NCBI NCBI Bookshelf.
- Subject
- Genre/Form
- Technical reports
- Technical reports.
- Note
- "Evidence-based synthesis program."
- "January 2012."
- Bibliography (note)
- Includes bibliographical references (pages 29-32).
- Funding (note)
- Prepared for: Department of Veterans Affairs, Veterans Health Administration, Health Services Research & Development Service, Washington, DC 20420. Prepared by: Evidence-based Synthesis Program (ESP) Center, Portland VA Medical Center, Portland, OR, Devan Kansagara, MD, MCR, Director
- VA-ESP
- Source of Description (note)
- Description based on online resource; title from PDF cover (VA, viewed April 23, 2021).
- Call Number
- GPO Internet VA 1.107/3:N 95
- OCLC
- 794257303
- Author
Kansagara, Devan, author.
- Title
Nutritional supplements for age-related macular degeneration : a systematic review / prepared for, Department of Veterans Affairs, Veterans Health Administration, Health Services Research & Development Service ; prepared by, Evidence-based Synthesis Program (ESP) Center, Portland VA Medical Center ; investigators, Devan Kansagara [and others].
- Publisher
Washington, DC : Department of Veterans Affairs, Veterans Health Administration, Health Services Research & Development Service, 2012.
- Description
1 online resource (iv, 43 pages) : illustrations
- Type of Content
text
- Type of Medium
computer
- Type of Carrier
online resource
- Series
Online access: NCBI NCBI Bookshelf.
- Bibliography
Includes bibliographical references (pages 29-32).
- Summary
Age-related macular degeneration (AMD) is the leading cause of irreversible vision loss in the developed world. In 2004, AMD affected 1.75 million persons in the United States, a number that is expected to rise to nearly 3 million by 2020 due to the aging of the population. The severity of macular degeneration ranges from Category 1 (least severe) to Category 4 (most severe), and "advanced AMD" is defined as having geographic atrophy involving the center of the macula or features of choroidal neovascularization. Observational studies suggest that people with dietary intakes higher in various carotenoids, antioxidants and omega-3 fatty acids have a lower risk of developing AMD. This has led to several supplementation trials designed to examine the ability of nutritional supplement with carotenoids, antioxidants, or omega-3 fatty acids to prevent the progression of AMD. Our report focuses on the evidence documenting the potential benefits and harms of certain dietary supplements in patients with AMD. We conducted a systematic review of published literature to address the following key questions: In patients with age-related macular degeneration, do nutritional supplements containing carotenoids, antioxidants, or omega-3 fatty acids alone or in combination prevent functional visual loss? In adult populations, what are the harms of carotenoid, antioxidant, and omega-3 fatty acid supplementation?
- Funding
Prepared for: Department of Veterans Affairs, Veterans Health Administration, Health Services Research & Development Service, Washington, DC 20420. Prepared by: Evidence-based Synthesis Program (ESP) Center, Portland VA Medical Center, Portland, OR, Devan Kansagara, MD, MCR, Director
VA-ESP 05-225
- Connect to:
- Added Author
United States. Department of Veterans Affairs. Health Services Research and Development Service, issuing body.
Portland VA Medical Center. Evidence-based Synthesis Program Center.
Evidence-based Synthesis Program (U.S.)
- Gpo Item No.
0985-A-12 (online)
- Sudoc No.
VA 1.107/3:N 95
- Research Call Number
GPO Internet VA 1.107/3:N 95